Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks

The economics of antibiotics can be improved by infectious diseases–specific clinical trial networks. While developers would still need to implement an independent phase 1 program as well as studies focused on highly resistant pathogens, standardized procedures in a network focused on usual drug res...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonnell, Anthony, Rex, John H., Goossens, Herman, Bonten, Marc, Fowler, Vance G., Dane, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Facilitating Antibacterial Drug Development in A Time of Great Need
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967592/
https://www.ncbi.nlm.nih.gov/pubmed/27481955
http://dx.doi.org/10.1093/cid/ciw244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967592/
https://www.ncbi.nlm.nih.gov/pubmed/27481955
http://dx.doi.org/10.1093/cid/ciw244

Ejemplares similares